Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma

Urothelial carcinoma (UC) occupies a high incidence among all the genitourinary malignancies. Immune checkpoint inhibitors (ICIs), as alternative treatments of metastatic urothelial carcinoma (mUC), have been applied in the treatment of mUC after chemotherapy failure, with comparable efficacy and sa...

全面介绍

书目详细资料

Principais autores:	Di Wang, Kai Sun, Tianqi Wang, Dongxu Zhang, Fengze Sun, Yuanshan Cui, Hongwei Zhao, Jitao Wu
格式:	Artigo
语言:	Inglês
出版:	Frontiers Media S.A. 2021-11-01
丛编:	Frontiers in Pharmacology
主题:	urothelial carcinoma (UC) immune checkpoint inhibitor (ICI) immune-related adverse events (irAEs) programmed cell death protein 1 (PD1) programmed cell death ligand protein 1 (PD-L1)
在线阅读:	https://www.frontiersin.org/articles/10.3389/fphar.2021.710943/full
标签:	添加标签 没有标签, 成为第一个标记此记录!